World's Richest Doctor Accused of Diverting Donations Back to His Own Companies

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-nantkwest-patrick-soon-shiong.jpg" NAME"World's Richest Doctor Accused of Diverting Donations Back to His Own Companies" ALT"World's Richest Doctor Accused of Diverting Donations Back to His Own Companies"March 7, 2017By Alex... Source:…

Continue ReadingWorld's Richest Doctor Accused of Diverting Donations Back to His Own Companies

Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month" ALT"Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month"March 7, 2017By Alex Keown,…

Continue ReadingWhy Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month

Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roivant-vivek-ramaswamy.jpg" NAME"Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina" ALT"Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina"March 6, 2017By Alex Keown...…

Continue ReadingBiotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina

The Elephant in the Room—Investors Pushing for Lower Pay for 1st Female GlaxoSmithKline CEO

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-glaxosmithkline.jpg" NAME"The Elephant in the Room--Investors Pushing for Lower Pay for 1st Female GSK CEO" ALT"The Elephant in the Room--Investors Pushing for Lower Pay for 1st Female GSK CEO"March…

Continue ReadingThe Elephant in the Room—Investors Pushing for Lower Pay for 1st Female GlaxoSmithKline CEO